RESTAT
Hospitals and Health CareIllinois, United States501-1000 Employees
Catamaran is now OptumRx. In order to receive the most updated information, please follow us at Optum.
Market Positioning As part of the Optum family, Catamaran (now OptumRx) operates within a leading healthcare services segment, providing opportunities to collaborate with large-scale healthcare platforms that prioritize integrated healthcare and pharmacy benefits.
Growth Potential With a revenue range between 250 million to 500 million and a sizeable employee base, there is significant scope for expanding service offerings and technology solutions to meet the needs of a growing healthcare organization.
Technology Stack Utilizing HSTS indicates adoption of modern security and web standards, which suggests a receptive environment for advanced healthcare IT solutions, including data security, compliance, and patient information management.
Competitive Edge Compared to larger competitors like CVS Health and Prime Therapeutics, Catamaran’s positioning offers tailored opportunities for innovative pharmacy management solutions, especially as healthcare companies seek cost efficiencies and improved patient outcomes.
Industry Trends Focusing on the hospital and healthcare industry with a recent rebranding signals alignment with evolving healthcare models that emphasize integrated health services, making it a strategic partner for digital transformation initiatives.
RESTAT uses 1 technology products and services including HSTS, and more. Explore RESTAT's tech stack below.
| RESTAT Email Formats | Percentage |
| First.Last@catamaranrx.com | 95% |
| FLast@catamaranrx.com | 3% |
| LastF@catamaranrx.com | 2% |
| First.Last@sxc.com | 93% |
| Last@sxc.com | 4% |
| Last.First@sxc.com | 2% |
| F.Last@sxc.com | 1% |
Hospitals and Health CareIllinois, United States501-1000 Employees
Catamaran is now OptumRx. In order to receive the most updated information, please follow us at Optum.
RESTAT's revenue is estimated to be in the range of $250M$500M
RESTAT's revenue is estimated to be in the range of $250M$500M